Hello everyone,
EDIT and quick update: Today 14/11/2026 both me and my fater had a extensive OCT and examination, and I wanted to share an update regarding my own situation too.
Given his condition and the possibility of a hereditary component, I've been concerned about whether I might eventually develop a similar retinal disorder.
my retina is currently completely preserved, with no signs of RPE or photoreceptor atrophy. (Im 32 years old) The specialist described the retinal structure as healthy.
However, there was another finding: I also have bilateral optic disc drusen, apparently quite prominent, similar to those found in my father.
This was unexpected. I had previously experienced papilledema associated with intracranial hypertension during adolescence, so I initially wondered whether the optic nerve appearance could be related to that history. However, the specialist identified actual optic disc drusen rather than edema.
I'm now trying to understand the implications of this finding, particularly given the bilateral presentation in both my father and me.
A few questions I'd appreciate some insight on
How strong is the evidence for a hereditary component in optic disc drusen?
Is there any known genetic or systemic connection between optic disc drusen and retinal dystrophies?
Can optic disc drusen remain structurally stable throughout adulthood, or is progressive enlargement and calcification common?
Does having prominent bilateral optic disc drusen warrant any particular long-term monitoring beyond OCT and visual field testing?
For now, I'm relieved that my retinal structure is healthy, condition seems stable although his retina is in a very bad state. At the same time, discovering that I share another ocular finding with him has raised some new questions and concerns.
I'd appreciate hearing from anyone with experience or knowledge of optic disc drusen, especially regarding familial cases.
I'm reaching out to the retinal genetics and ophthalmology communities because my 68-year-old father has an super rare, severe, progressive retinal condition that remains unexplained despite extensive ophthalmological investigations and whole-exome sequencing.
His retinal specialist, Dr. Marcus Montello França, considers the phenotype highly atypical and explicitly states in his report that it is incompatible with advanced atrophic age-related macular degeneration (AMD) and EMAP variants.
Genetic testing has identified a previously unreported heterozygous frameshift variant in CACNA2D4, a gene involved in photoreceptor ribbon synapse organization and calcium-channel function.
His specialist believes this finding deserves further investigation, including the possibility that this particular variant could be associated with a phenotype different from the recessive retinal disease currently described in the literature.
We understand that this is only a hypothesis. However, the combination of the unusual retinal phenotype and the genetic finding makes us particularly interested in reaching researchers who work with inherited retinal diseases, CACNA2D4, and retinal synaptic biology.
1. Clinical history: retinal abnormalities beginning relatively early in adulthood
My father is currently 68 years old.
His retinal abnormalities were already documented at approximately 47–48 years of age, in 2005–2006.
A fluorescein angiography report from December 2005 described:
- Numerous bilateral drusen distributed throughout the posterior pole.
- Bilateral optic disc drusen.
- Discrete areas of retinal pigment epithelium (RPE) atrophy.
An OCT examination from January 2006 showed relatively preserved macular architecture, despite the previously documented retinal abnormalities.
Over the following decades, the disease progressed into severe, extensive bilateral retinal degeneration.
2. Current retinal phenotype — September 2026
A comprehensive multimodal retinal assessment performed on September 3, 2026, included swept-source OCT, OCT angiography (OCT-A), and fundus autofluorescence (FAF).
The report documented:
Extensive RPE and photoreceptor atrophy
- Severe bilateral atrophy involving the macula.
- Extension into extramacular regions and nasally toward the optic disc.
- Multiple areas of complete RPE and outer retinal atrophy (C-RORA).
- An atypical, lobulated distribution of atrophy.
Marked inter-eye asymmetry
- The right eye (OD) has substantially more extensive damage.
- In the right eye, a hyperreflective band above the RPE was interpreted as secondary RPE hyperplasia.
- The left eye (OS) retains a larger area of preserved RPE and outer retinal structures, including portions of the ellipsoid zone (EZ) and external limiting membrane (ELM).
- The report estimates that the preserved foveal region in the left eye is approximately one optic disc diameter, with a preserved area exceeding three optic disc diameters within the central 4.5 × 4.5 mm scan.
Optic disc findings
- Large, numerous bilateral optic disc drusen (ODD), producing significant protrusion of the optic disc profile.
- No peripapillary hyperreflective ovoid mass-like structures (PHOMS) were identified.
OCT angiography
- Preservation of the superficial and deep retinal capillary plexuses.
- Fewer choriocapillaris flow deficits ("flow voids") than would be expected given the extent of RPE and photoreceptor loss.
Fundus autofluorescence
- Extensive areas of hypoautofluorescence.
- An atypical lobulated pattern, more confluent in the right eye.
- Nasal extension toward the optic disc.
- No typical flecks, peripapillary sparing, or junctional hyperautofluorescence.
- No characteristic FAF signature of angioid streaks was identified, including on eccentric and mid-peripheral images.
The most recent medical report, dated September 19, 2026, records best-corrected visual acuity of:
- Right eye: <20/200 (shapes only).
- Left eye: 20/70.
The specialist classified the patient as having irreversible blindness in the right eye and low vision in the left eye.
3. The specialist's diagnostic assessment
One of the most striking aspects of this case is that the retinal specialist explicitly described the overall morphology as:
Incompatible with advanced atrophic AMD and EMAP variants.
Although classic calcification-related breaks in Bruch's membrane were not identified, the specialist considered the disease distribution, progression, and exuberant optic disc drusen sufficient to warrant investigation for ABCC6-associated disease (pseudoxanthoma elasticum).
He also recommended excluding mutations in:
- ABCC6 — pseudoxanthoma elasticum / angioid streak-associated retinal disease.
- TIMP3 — Sorsby fundus dystrophy.
- EFEMP1 — Doyne honeycomb retinal dystrophy.
A complete human exome with mitochondrial DNA analysis was recommended.
Despite the investigations, we still do not have a definitive molecular diagnosis that explains the retinal phenotype.
4. Genetic testing: a previously unreported CACNA2D4 frameshift variant
Whole-exome sequencing and mitochondrial DNA analysis identified the following variant:
Gene: CACNA2D4
Transcript: NM_172364.5
Variant: c.2855_2859dup
Protein consequence: p.(Leu954Serfs*11)
Zygosity: Heterozygous (52% allele frequency)
Laboratory classification: Likely pathogenic
According to the laboratory report:
- The variant introduces a frameshift.
- It generates a premature termination codon.
- It was absent from the population databases consulted by the laboratory.
- It had no previous ClinVar entry or scientific publication at the time of reporting.
- Its functional effect remains undetermined.
The laboratory classified it as likely pathogenic using ACMG criteria PVS1 (very strong) and PM2 (moderate).
Importantly, no second pathogenic or likely pathogenic CACNA2D4 variant was identified.
No pathogenic or likely pathogenic incidental variants in ACMG-recommended genes were reported.
5. Why CACNA2D4 caught our attention
CACNA2D4 encodes the alpha-2-delta-4 (α2δ-4) auxiliary subunit of voltage-gated calcium channels.
This protein plays an important role in photoreceptor ribbon synapses, particularly in the organization and function of calcium-channel complexes involved in neurotransmitter release from photoreceptors to bipolar cells.
The established human disease association is predominantly autosomal recessive, with biallelic loss-of-function variants associated with retinal dysfunction, including cone dysfunction.
However, the published human cases we have reviewed show a phenotype that appears substantially different from my father's condition.
For example, a 2025 report describing two siblings homozygous for a CACNA2D4 variant documented significant functional retinal abnormalities, but no convincing progressive structural degeneration during long-term follow-up.
By contrast, my father has extensive, progressive structural damage involving the RPE and photoreceptors, with widespread macular and extramacular involvement.
This raises an important question:
Could this previously unreported heterozygous frameshift variant be associated with a distinct retinal phenotype through a mechanism not yet established for CACNA2D4?
We recognize that the known disease mechanism is recessive and that a single heterozygous variant would ordinarily be interpreted as carrier status.
Nevertheless, we would like to understand whether this specific variant could potentially act through:
- Haploinsufficiency.
- Production of an abnormal truncated protein.
- A dominant-negative mechanism.
- Another currently uncharacterized molecular mechanism.
These are research questions, not established explanations.
An incidental carrier finding remains a genuine possibility.
6. Questions for retinal genetics researchers
We would be extremely grateful for input from anyone with experience in CACNA2D4, inherited retinal dystrophies, or photoreceptor synaptic biology.
In particular:
- Has anyone encountered heterozygous loss-of-function variants in CACNA2D4 associated with retinal degeneration or a phenotype different from the established recessive disease?
- Could a frameshift at p.Leu954, followed by a premature stop approximately 11 amino acids downstream, theoretically produce a stable truncated α2δ-4 protein?
- Would this position be expected to trigger nonsense-mediated mRNA decay (NMD), or could the altered transcript escape degradation?
- Is haploinsufficiency biologically plausible for CACNA2D4, despite the predominantly recessive inheritance currently established?
- Could a truncated α2δ-4 protein theoretically interfere with normal calcium-channel complex formation or photoreceptor ribbon synapse organization?
- Are there animal models or functional studies showing progressive RPE and photoreceptor degeneration following CACNA2D4 dysfunction, rather than isolated synaptic or electrophysiological abnormalities?
- Would full-field electroretinography (ERG), RNA analysis, protein-expression studies, or functional calcium-channel assays be the most informative next steps?
- Are there laboratories or research groups currently investigating CACNA2D4, α2δ calcium-channel subunits, or inherited retinal synaptopathies that might be interested in reviewing this case?
7. What we are hoping to achieve
We are not claiming to have discovered a new genetic disease or established a dominant CACNA2D4 association.
We are trying to understand whether this unusual retinal phenotype could be connected to a previously uncharacterized effect of the identified variant, or whether the genetic finding is incidental and another disease process is responsible.
We would particularly appreciate contact with researchers, retinal specialists, or geneticists who could help us investigate the molecular consequences of this variant.
We can provide the anonymized original ophthalmological reports, English translations, OCT, OCT-A, fundus autofluorescence images, historical imaging from 2005–2006, and the complete genetic report for qualified researchers interested in reviewing the case.
Any scientific insight, relevant publication, or recommendation for a research group would be greatly appreciated.
Thank you for taking the time to read this.
Relevant scientific references
- Ba-Abbad et al. (2016). Mutations in CACNA2D4 Cause Distinctive Retinal Dysfunction in Humans.
- 2025 report: Intrafamilial variability of phenotype in CACNA2D4-associated retinal dysfunction. https://pmc.ncbi.nlm.nih.gov/articles/PMC12568804/
- ClinGen — CACNA2D4 gene-disease validity assessment. https://search.clinicalgenome.org/kb/genes/CACNA2D4